Temporal Association Between PLA2R Antibodies and Clinical Outcomes in Primary Membranous Nephropathy
Autoantibodies to M-type phospholipase A2 receptor (aPLA2R) are seen in two-thirds of patients with primary membranous nephropathy (PMN) and are associated with disease activity. However, the precise temporal dynamics between the presence and amount of aPLA2R in circulation, as well as the clinical...
Main Authors: | R. Ramachandran, A.K. Yadav, V. Kumar, N. Inamdar, R. Nada, K.L. Gupta, V. Jha |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | Kidney International Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S246802491730387X |
Similar Items
-
The Intensity of PLA2R and C4d Immunoexpression in Primary Membranous Nephropathy
by: Deniz Filinte, et al.
Published: (2020-06-01) -
Membranous Nephropathy (MN) Recurrence After Renal Transplantation
by: Patrizia Passerini, et al.
Published: (2019-06-01) -
Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy
by: Anne-Els van de Logt, et al.
Published: (2021-06-01) -
An Evaluation of the Level of Anti-phospholipase A2 Receptor (PLA2R) Antibody in Different Pathological Types of Glomerulonephritis
by: F Sadadi, et al.
Published: (2017-02-01) -
Horseshoe kidney with PLA2R-positive membranous nephropathy
by: Shuai-Shuai Shi, et al.
Published: (2021-08-01)